Trials / Not Yet Recruiting
Not Yet RecruitingNCT07473427
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Accepted
Summary
This is a single armed, Phase 3 study to assess the immunogenicity and safety of the varicella vaccine manufactured by Sinovac. A total of 300 healthy participants aged 1-12 years will be enrolled. All participants will receive a single dose of varicella vaccine manufactured by Sinovac.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Varicella Vaccine | Varicella vaccine manufactured by Sinovac |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2026-08-01
- Completion
- 2026-10-01
- First posted
- 2026-03-16
- Last updated
- 2026-03-16
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT07473427. Inclusion in this directory is not an endorsement.